Provided by Tiger Trade Technology Pte. Ltd.

XTALPI

6.875
-0.050-0.72%
Volume:22.42M
Turnover:155.23M
Market Cap:29.58B
PE:229.17
High:7.020
Open:6.920
Low:6.865
Close:6.925
52wk High:15.120
52wk Low:6.300
Shares:4.30B
HK Float Shares:4.30B
Volume Ratio:0.63
T/O Rate:0.52%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.030
ROE:-2.06%
ROA:-5.20%
PB:2.81
PE(LYR):229.17
PS:37.27

Loading ...

Xtalpi - Announces Strategic Partnership With Potential Deal Value Over $400 Mln

THOMSON REUTERS
·
Jun 09

Xtalpi - Partner to Provide Upfront Payment and Fund Early R&D; Xtalpi Eligible for Milestones and Royalties

THOMSON REUTERS
·
Jun 09

Xtalpi - Announces Strategic Partnership With Deal Value Over US$400 Mln

THOMSON REUTERS
·
Jun 09

Xtalpi Holdings Ltd - Strategic Partnership With a Leading Biopharma Company to Develop Oral Small Molecule Therapeutics for a Gpcr Target

THOMSON REUTERS
·
Jun 09

XtalPi partners with international biopharma on GPCR oral small-molecule program worth over USD 400 million

Reuters
·
Jun 09

BRIEF-Xtalpi To Repurchase Shares Up To $100 Million

Reuters
·
Jun 09

XTALPI Authorizes Up to $1 Billion for Share Repurchases in Open Market

Stock News
·
Jun 09

XTALPI Announces US$100.00 Million On-Market Share Repurchase, Covering Up to 10% of Issued Shares

Bulletin Express
·
Jun 09

Xtalpi Holdings Ltd - Will Repurchase Shares From 10 June to Conclusion of Next Annual General Meeting

THOMSON REUTERS
·
Jun 09

Xtalpi - to Repurchase Shares up to US$100 Mln

THOMSON REUTERS
·
Jun 09

XtalPi launches on-market share buyback of up to US$ 100 million

Reuters
·
Jun 09

Movement Alert|XtalPi Holdings Falls 5.07% in Regular Trading, Trading at 7.12 HKD

Market Focus
·
Jun 08

Assessing XtalPi Holdings (SEHK:2228) Rich Valuation After Strong Growth And Recent Share Price Pullback

Simply Wall St.
·
Jun 01

XTALPI (02228) Announces Two Breakthroughs in Self-Developed Innovative Peptide Food Ingredient and Incubated Company's Drug Pipeline

Stock News
·
May 31

XTALPI secures US Self-GRAS status for peptide Tensotide and early FDA IND nod for pan-TEAD inhibitor SIGX2649

Bulletin Express
·
May 31

BRIEF-XtalPi Receives Second Payment From DoveTree Under Strategic Collaboration

Reuters
·
May 30

XtalPi receives US $19 million second payment from DoveTree under drug discovery pact

Reuters
·
May 29

Xtalpi - Receives Second Payment From Dovetree Under Strategic Collaboration

THOMSON REUTERS
·
May 29

Strategic Partnership with DoveTree Advances, XTALPI's (02228) Platform Value Gains Dual Recognition from Industry and Market

Stock News
·
May 29

XtalPi Receives Further $19 Million Under Drug Discovery Agreement With DoveTree

MT Newswires Live
·
May 28